Document is current
Any future updates will be listed below
-
Authors
Chu, Jacqueline J.
Tadros, Audree B.
Gallo, Lucas
Mehrara, Babak J.
Morrow, Monica
Pusic, Andrea L.
Voineskos, Sophocles H.
Nelson, Jonas A.
-
Funding
Funding for this research was provided by:
NIH/NCi Cancer Center Support Grant (P30CA008748)
- License Information
-
More Information
Article History
Received: 28 December 2022
Accepted: 24 January 2023
First Online: 25 February 2023
Disclosure
: The preparation of this study was supported in part by NIH/NCI Cancer Center Support Grant P30 CA008748 to Memorial Sloan Kettering Cancer Center. This study was presented in poster format at the 44th Annual San Antonio Breast Cancer Symposium, December 7–10, 2021, San Antonio, TX. Dr. Babak Mehrara reports receipt of an investigator-initiated grant from Pfizer, Regeneron, and Puretech, receipt of royalty payments from Puretech, and an advisory position with Mediflix. Dr. Andrea L. Pusic is a co-developer of the BREAST-Q and receives totalities when it is used in for-profit, industry-sponsored, clinical trials. All other authors have no conflicts of interest to disclose.
